Načítá se...
Skin cancer in solid organ transplant recipients: are mTOR inhibitors a game changer?
While immunosuppressive agents are necessary to prevent the rejection of transplanted organs, and are a great medical success story for protecting against early allograft loss, graft and patient survival over the long term are diminished by side effects from these same drugs. One striking long-term...
Uloženo v:
| Vydáno v: | Transplant Res |
|---|---|
| Hlavní autor: | |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
BioMed Central
2015
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4332735/ https://ncbi.nlm.nih.gov/pubmed/25699174 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13737-014-0022-4 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|